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vented the conventional postdoctoral route. The lackDon C. Wiley (1944–2001)
of a transitional period, within which to find a worthy
research goal, was the source of considerable stress,
as Don recounted in an interview with Sondra Schle-
singer (see http://medicine.wustl.edu/virology/wiley.
htm). For Don was not a person to consider, even for aDon Wiley changed how we picture molecular organiza-
moment, a “bread-and butter” project to back up histion at the cell surface. Indeed, he helped to create how
more ambitious strivings. His determination never towe picture it. His two monumental contributions, the
waste time on something ordinary was probably rein-structures of influenza virus hemagglutinin in its various
forced by the influence of Jim Watson, an intense scien-states and the structures of class I and class II MHC
tific presence in the Harvard of the 60s and 70s. Inmolecules in combination with peptides, superantigens,
any case, by 1974, he had found a direction that wouldand T cell receptors, redefined molecular virology and
dominate the rest of his career, by seizing upon viralimmunology. He was one of the pioneers who trans-
surface glycoproteins—the influenza virus hemaggluti-formed the specialty then known as “protein crystallog-
nin (HA) in particular—as a route toward unraveling theraphy” into the discipline we now call “structural
molecular mechanisms of cell-cell recognition. Of Don’sbiology.”
success in turning this part of cell biology into crystallog-Don burst upon the scene of protein crystallography
raphy, Max Perutz once wrote that Don had now “donein 1971, at the landmark Cold Spring Harbor Symposium
the impossible—twice.” The first time was, of course,on Protein Structure. Fresh from the triumph of a 5.5 A˚
his graduate-student success with ATCase.structure of aspartate transcarbamoylase (ATCase) and
Skeptics tried to dissuade Don from studying virala recently completed PhD thesis, he arrived from Cam-
glycoproteins. These were known to have somewhatbridge in a newly acquired sports car. He continued to
variable glycosylation, and there were even doubtscut a dashing figure throughout the meeting. He had
about the rigidity of their protein components. Don fig-been recruited (from Tufts) to the Biophysics graduate
ured that he would worry about such issues when theprogram at Harvard by Donald Caspar, who remained
time came: you can always talk yourself out of a chal-
an important intellectual influence, but he was ultimately
lenge, and the real trick is to avoid crippling inhibitions.
lured by the ATCase project to pursue thesis research
Don was enormously fortunate in finding John Skehel
in William Lipscomb’s laboratory in the Department of
as a collaborator on the HA project, as was John in
Chemistry. In 1967, the structural basis of allosteric reg-
finding Don. Skehel published an account of the prepa-
ulation was a major (and contentious) problem. It repre-
ration and apparent crystallization of soluble HA in 1972.
sented the “next level” of structural complexity, beyond Don contacted him when he first read the paper, almost
the three or four simple enzymes for which atomic reso- two years later. They built up a striking scientific and
lution models were then at hand. By 1971, Don had personal friendship. Don spent six months in Skehel’s
changed all that, not yet by fully solving the problem laboratory in Mill Hill, pushing the project forward, and
of course—that took another two decades of work in they spoke on the telephone at least weekly, and some-
Lipscomb’s laboratory—but by defining the route to an times more often, during the ensuing decades. Don and
answer. I were also jointly fortunate that Harvard had allowed
I first met Don shortly after he arrived at Harvard. I us to establish a shared laboratory. Each of us was able
was a student in Caspar’s laboratory in the so-called to contribute to the other’s progress and to provide
“Jimmy Fund” Building of the Children’s Cancer Re- encouragement in the inevitable intervals of perceived
search Foundation, and Don did an extended rotation despair. By 1977, Don had also succeeded in recruiting
there. He carried out diffraction experiments on lipid a superb postdoctoral fellow, Ian Wilson (now at the
phases, perhaps nucleating his career-long interest in Scripps Research Institute), who was instrumental in
membranes. We collaborated while he was a graduate pushing the HA effort to completion.
student, working out how to use the newly introduced The HA structure was completed in 1980, and back-to-
rotating-drum film scanners to index and integrate pre- back papers describing the molecule and its antigenic
cession and, later, oscillation photographs. We were properties were published in Nature in 1981. It redefined
recruited by the Department of Biochemistry and Molec- in molecular language the three central properties of
ular Biology in the same year, and when Don accepted the protein—receptor binding, antigenic variation, and
his appointment, a few months after I accepted mine, membrane fusion. Almost overnight, vast areas of virol-
he came to propose that we set up our laboratories ogy had become chemistry. Don later said that he be-
together. Sitting in my tutor’s room in Lowell House, lieved that “the discovery” was actually not the struc-
we fantasized how would we build up what we called ture, but an experiment, motivated by the structure,
“structural molecular biology” (a phrase we had learned carried out by John Skehel in the following year (see
from Caspar and Carolyn Cohen) amidst the “informa- Schlesinger interview). Skehel showed that HA under-
tional molecular biology” then reigning in Cambridge, goes a dramatic conformational change at low pH, ac-
Massachusetts. quiring membrane-protein-like properties. The word
Don joined the Harvard faculty immediately upon “discovery” had a special meaning for Don—not just a
completed observation, however important and how-completing his degree—an unusual step that circum-
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ever hard-won, but rather a qualitative insight, preferably them on the cell surface. The notion of presentation was
still rather vague, however, and a picture was essential,formulated in a few simple sentences, or in a simple
drawing. not just to prove the notion but also to work out how to
refine it. The structure did just that. For sitting betweenSkehel’s discovery led to the second phase of work
on HA—efforts to define the structural transformations two -helical “rails” on the outer surface of the molecule
was the now famous “extra density,” promptly ascribedthat accompany viral entry. A graduate student, Bill Weis
(now at Stanford), obtained the first glimpse of receptor to bound antigenic peptide. Results from many labora-
tories then came thick and fast, characterizing boundbinding in 1987, but it was not until 1994 that two post-
doctoral fellows in the laboratory, Fred Hughson (now peptides and establishing the principles of their incorpo-
ration.at Princeton) and Per Bullough (now at University of
Sheffield) revealed the remarkable transformation that Seeing the extra density was definitely a “discovery,”
and it strongly influenced Don’s scientific directions.HA undergoes at low pH. Many of us did not believe,
before that moment, that proteins could really do such During the decade and a half since the 1987 paper, he
and his laboratory turned that first glimpse of what thethings. It revised our concept of conformational change.
By the late 1970s, Jack Strominger’s laboratory at T cell receptor really sees into an entire library of con-
cepts and images. Working with Don, Dean MaddenHarvard had found ways to prepare significant quantities
of the HLA major histocompatibility antigen, originally (now at Dartmouth) analyzed the structural principles of
peptide binding by class I MHC proteins; Ted Jardetzkydiscovered as the principal determinant of transplant
rejection, but already by that time known to be a crucial (now at Northwestern), Larry Stern (now at MIT), and
Jerry Brown (now at Brandeis) determined the structurescomponent of the T cell-mediated immune response.
Don’s progress in studying influenza HA made him the of class II molecules; and David Garboczi (now at NIH)
and Partho Ghosh (now at UCSD) finally crystallizedobvious collaborator in an effort to visualize HLA. Pam-
ela Bjorkman, a graduate student (now an HHMI Investi- T cell receptor complexes and could look at MHC mole-
cules “as the TCR sees them.” Recognition and prizesgator at Caltech), undertook to crystallize it and to deter-
mine its structure. The outcome in 1987 was a turning came in abundance (the Louisa Gross Horwitz, Gairdner,
Lasker, and Japan Prizes, to name a few), but Don re-point in immunology. Various lines of evidence had led
to the notion that major histocompatibility molecules like mained strikingly unaffected by the glamor, his thoughts
still fixed on what discoveries might come next.HLA would bind antigen-derived peptides and “present”
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The year 1987 marked not only the revolution brought I would wander into his office at the end of almost every
about by the HLA structure, but also a transition in the day that we were both in town, to talk about our science
research group. The shared laboratory that Don and I and to seek or give advice. These conversations were
had founded was adopted by the Howard Hughes Medi- often terminated only by a phone call from home, pre-
cal Institute, and together we established a second labo- sumably announcing dinner. I miss intensely those re-
ratory in the HHMI Unit at Children’s Hospital—almost markable encounters, just as the rest of Don’s extended
a return to our common roots in the old Jimmy Fund scientific family mourns the loss—probably larger than
Building, one block away. The HHMI transition allowed any of us yet realizes—of his powerful yet unpretentious
both of us to expand our scientific scope and to under- intellectual presence.
take even riskier projects. One example was our joint
resolve to contribute what we could to the general effort Stephen C. Harrison
to understand HIV. I believe that a particularly fulfilling Department of Molecular and Cellular Biology
moment for Don came when Winfried Weissenhorn (now Harvard University
at EMBL) worked out the structure of a truncated form Cambridge, Massachusetts 02138
of the HIV-1 gp41 trimer in the conformation it adopts Department of Biological Chemistry
after the fusion-activating transition. I recall how Don and Molecular Pharmacology
told me on the phone that the structure was at last done Harvard Medical School
and that there might be a “discovery”—the N and C Boston, Massachusetts 02115
termini of the gp41 ectodomain were adjacent in space Laboratory of Molecular Medicine
after the transition. He believed that this would be true Children’s Hospital
for influenza HA (Jue Chen later showed that it was),
Boston, Masachusetts 02115
but the Hughson-Bullough structure had not quite es-
Howard Hughes Medical Institute
tablished it. The implication was that these fusion pro-
teins were instruments for forcing two bilayers into prox- Correspondence: schadmin@crystal.harvard.edu
imity and that the function of the conformational change
was to squeeze them together.
I have said that Don’s view of significant scientific
observations was embodied in his use of the word “dis-
covery”; his integration of discoveries into a picture of
external reality was communicated through the simplic-
ity of a cartoon. Clear, well-established notions, such
as the way a T-killer cell recognizes the antigen pre-
sented by its target, could be summarized in a few drawn
lines and a few short words. Don hated obfuscation
or irrelevant detail; the little “Etc” in the drawing here
probably wraps up more than half the papers in J Exp.
Med. during the last decade! The mesmerizing charm
of this cartoon also encapsulates some of Don’s intellec-
tual and personal charisma. Four o’clock teatime in the
laboratory became an institution when we were still both
crammed into about a thousand shabby but wonderful
square feet in the now vanished Gibbs Laboratory at
Harvard, and continued when we acquired our own little
tea room in the new Fairchild Building. When in the right
mood, Don could hold forth at teatime for an hour or
more, with his laboratory members (and mine) arrayed
around him like iron filings near a magnet. At such mo-
ments, and at scientific conferences, he had a larger-
than-life presence, enhanced by his chiaroscuro affecta-
tion of wearing nothing but black or black-and-white.
He was a superb mentor of graduate students, and from
1980 to 1992 he chaired the Biophysics program that
had once granted him a PhD.
To two former postdoctoral fellows, now married to
each other, Don wrote recently on the occasion of the
birth of their first child: “This is the beginning of a great
adventure. I am not sure that anything changes your life
more than a child. Similarly, there is nothing more fun
or interesting.” When Don married Katrin Valgeirsdottir,
he learned Icelandic, and Iceland became an adopted
second home. He believed in family, and cared very
much about his own. He was also deeply conscious of
his scientific family—his current and former students
and postdoctoral fellows, his collaborators, his mentors.
